Celltrion Pharm

068760.KQ

41.10 USD

-0.27

-0.65%

Overview

Last close

41.10 usd

Market cap

1.78B usd

52 week high

52.45 usd

52 week low

30.18 usd

Target price

90.59 usd

Valuation

P/E

N/A

Forward P/E

49.505

Price/Sales

9.9156

Price/Book Value

6.3573

Enterprise Value

1.84B usd

EV/Revenue

5.3303

EV/EBITDA

36.458

Key financials

Revenue TTM

183.00M usd

Gross Profit TTM

53.85M usd

EBITDA TTM

28.51M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

532.45M usd

Net debt

86.52M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.